1-4 of 4
Michael Lill, MD, BS
Close
Sort by
Journal Articles

Pseudo-Progression Among Patients with Follicular Lymphoma Treated with Ibrutinib in the Phase 2 DAWN Study

Gilles A. Salles, Judith Trotman, MB ChB, Michael Lill, MD BS, Bruce Cheson, MD, Stephen J. Schuster, MD, Jing-Zhou Hou, John A Radford, MB ChB, MRCP, MD FRCP, Andrew Spencer, Michael Schaffer, PhD, Rajendra Damle, PhD, Gary J. Gartenberg, MD, Jessica Vermeulen, MD PhD, Sriram Balasubramanian, PhD, Sanjay Deshpande, MD, Dolores Caballero, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2980.
https://doi.org/10.1182/blood.V128.22.2980.2980
Published: 2016
Journal Articles

Ibrutinib As Treatment for Chemoimmunotherapy-Resistant Patients with Follicular Lymphoma: First Results from the Open-Label, Multicenter, Phase 2 DAWN Study

Ajay K. Gopal, MD, Stephen J. Schuster, MD, Nathan Fowler, MD, Judith Trotman, MBChB, Georg Hess, MD, Jing-Zhou Hou, Abdulraheem Yacoub, MD, Michael Lill, MD BS, Peter Martin, MD, Umberto Vitolo, MD, Wojciech Jurczak, MD, James Morton, MBBS, BSc(MD, FRACP, FRCPA, Dzhelil Osmanov, MD, Gary J. Gartenberg, MD, Jessica Vermeulen, MD PhD, Sriram Balasubramanian, PhD, Shean-sheng Wang, PhD, Sanjay Deshpande, MD, Gilles A. Salles
Journal: Blood
Blood (2016) 128 (22): 1217.
https://doi.org/10.1182/blood.V128.22.1217.1217
Published: 2016
Journal Articles

Mutational Landscape of Pediatric Acute Lymphoblastic Leukemia

Qiao-Yang Sun, PhD, Ling-wen Ding, PhD, Kar-Tong Tan, Wenwen Chien, Anand Mayakonda, Allen Eng Juh Yeoh, MD, Norihiko Kawamata, Yasunobu Nagata, MD,PhD, Xiao Jin-Fen, Xin-Yi Loh, De-Chen Lin, Manoj Garg, PhD, Yan-Yi Jiang, Liang Xu, Su-Lin Lim, Li-Zhen Liu, Vikas Madan, PhD, Masashi Sanada, MD PhD, Lucia Torres Fernández, Hema Preethi S.S., Michael Lill, MD BS, Hagop M. Kantarjian, MD, Steven M. Kornblau, MD, Satoru Miyano, PhD, Der-Cherng Liang, MD, Seishi Ogawa, MD PhD, Lee-Yung Shih, Henry Yang, PhD, H. Phillip Koeffler, MD
Journal: Blood
Blood (2016) 128 (22): 452.
https://doi.org/10.1182/blood.V128.22.452.452
Published: 2016
Journal Articles

Low CD34 Cell Dose Is Associated With Higher Non-Relapse and Overall Mortality After Reduced Intensity Conditioning Hematopoietic Cell Transplantation For Acute Myeloid Leukemia and Myelodysplastic Syndrome

Johan Thörlén, MD, Olle Ringdén, MD, PhD, Jennifer Le Rademacher, PhD, Minoo Battiwalla, MD, MS, Junfang Chen, MS, Vincent T. Ho, MD, Partow Kebriaei, MD, Carolyn A. Keever-Taylor, PhD, Tamila L. Kindwall-Keller, DO, Hillard M. Lazarus, MD, Mary J. Laughlin, MD, Michael Lill, MD, BS, Tracey A. O’Brien, FRACP, MBChB, MHL, BSc, Miguel Angel Perales, MD, Vanderson Rocha, MD, PhD, Bipin N. Savani, MD, David Szwajcer, MD, FRCPC, David Valcarcel, MD, Mary Eapen, MBBS, MS
Journal: Blood
Blood (2013) 122 (21): 3342.
https://doi.org/10.1182/blood.V122.21.3342.3342
Published: 2013